1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
1 of 4
FEATURED COMPANIES
- Abbott Laboratories
- Abiomed Inc.
- Asahi Kasei Corp.
- Biotronik Inc.
- Boston Scientific Corp.
- General Electric Co.
- MORE
Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market: About this market
The cardiac monitoring & cardiac rhythm management devices market analysis considers sales from both cardiac rhythm management devices and cardiac monitoring devices in Asia, Europe, North America, and ROW. In 2018, the cardiac rhythm management devices segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as rising product launches and the growing focus on R&D for the development of advanced devices will play a significant role in the cardiac rhythm management devices segment to maintain its market position. Also, our global cardiac monitoring & cardiac rhythm management devices market report looks at factors such as increasing prevalence of CVDs, increasing awareness initiatives and access to healthcare, and technological advances and new product launches. However, high costs of CM and CRM devices, shortage of skilled clinicians, and increasing enforcement of stringent regulations may hamper the growth of the cardiac monitoring & cardiac rhythm management devices industry over the forecast period.
Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market: Overview
Increasing awareness initiatives and access to healthcare
Public and private organizations are taking initiatives to promote awareness about CVDs and lung diseases. For instance, The Sudden Cardiac Arrest (SCA) Foundation is focusing on increasing awareness and influence attitudinal and behavioral changes for reducing mortality and morbidity from SCA. The Asia Pacific Heart Rhythm Society (APHRS) is another organization focusing on advancing the diagnosis and treatment of patients with heart rhythm disorders in APAC. Such initiatives by organizations lead to an increase in the diagnosis and treatment of CVDs leading to the expansion of the global cardiac monitoring & cardiac rhythm management devices market at a CAGR of almost 5% during the forecast period.
Increasing use of cardiac implants
Cardiac implants like pacemakers, ICDs, and CRT devices, are significantly increasing in several developing and developed countries. The significant improvements in the technology of cardiac implants and patient outcomes have improved experience and confidence of cardiac surgeons to operate on high-risk. Factors driving the utilization of cardiac implants are rising replacement rate of CRM devices; the increasing number of CRM devices implantation facilities; and the growing prevalence of CVDs. This development is expected to have a positive impact on the overall market growth.
Competitive Landscape
With the presence of a few major players, the global cardiac monitoring & cardiac rhythm management devices market is concentrated. The robust vendor analysis is designed to help clients improve their market position. In line with this, our report provides a detailed analysis of few leading cardiac monitoring & cardiac rhythm management devices manufacturers, that include Abbott Laboratories, Abiomed Inc., Asahi Kasei Corp., Biotronik Inc., Boston Scientific Corp., General Electric Co., Hill-Rom Holdings Inc., Koninklijke Philips NV, Medtronic Plc, SCHILLER AG.
Also, the cardiac monitoring & cardiac rhythm management devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The cardiac monitoring & cardiac rhythm management devices market analysis considers sales from both cardiac rhythm management devices and cardiac monitoring devices in Asia, Europe, North America, and ROW. In 2018, the cardiac rhythm management devices segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as rising product launches and the growing focus on R&D for the development of advanced devices will play a significant role in the cardiac rhythm management devices segment to maintain its market position. Also, our global cardiac monitoring & cardiac rhythm management devices market report looks at factors such as increasing prevalence of CVDs, increasing awareness initiatives and access to healthcare, and technological advances and new product launches. However, high costs of CM and CRM devices, shortage of skilled clinicians, and increasing enforcement of stringent regulations may hamper the growth of the cardiac monitoring & cardiac rhythm management devices industry over the forecast period.
Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market: Overview
Increasing awareness initiatives and access to healthcare
Public and private organizations are taking initiatives to promote awareness about CVDs and lung diseases. For instance, The Sudden Cardiac Arrest (SCA) Foundation is focusing on increasing awareness and influence attitudinal and behavioral changes for reducing mortality and morbidity from SCA. The Asia Pacific Heart Rhythm Society (APHRS) is another organization focusing on advancing the diagnosis and treatment of patients with heart rhythm disorders in APAC. Such initiatives by organizations lead to an increase in the diagnosis and treatment of CVDs leading to the expansion of the global cardiac monitoring & cardiac rhythm management devices market at a CAGR of almost 5% during the forecast period.
Increasing use of cardiac implants
Cardiac implants like pacemakers, ICDs, and CRT devices, are significantly increasing in several developing and developed countries. The significant improvements in the technology of cardiac implants and patient outcomes have improved experience and confidence of cardiac surgeons to operate on high-risk. Factors driving the utilization of cardiac implants are rising replacement rate of CRM devices; the increasing number of CRM devices implantation facilities; and the growing prevalence of CVDs. This development is expected to have a positive impact on the overall market growth.
Competitive Landscape
With the presence of a few major players, the global cardiac monitoring & cardiac rhythm management devices market is concentrated. The robust vendor analysis is designed to help clients improve their market position. In line with this, our report provides a detailed analysis of few leading cardiac monitoring & cardiac rhythm management devices manufacturers, that include Abbott Laboratories, Abiomed Inc., Asahi Kasei Corp., Biotronik Inc., Boston Scientific Corp., General Electric Co., Hill-Rom Holdings Inc., Koninklijke Philips NV, Medtronic Plc, SCHILLER AG.
Also, the cardiac monitoring & cardiac rhythm management devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown
2 of 4
FEATURED COMPANIES
- Abbott Laboratories
- Abiomed Inc.
- Asahi Kasei Corp.
- Biotronik Inc.
- Boston Scientific Corp.
- General Electric Co.
- MORE
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 08: GEOGRAPHIC LANDSCAPE
Exhibit 01: Product overview
Exhibit 02: Global medical devices market
Exhibit 03: Segments of global medical devices market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Product - Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: Cardiac rhythm management devices - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Cardiac rhythm management devices - Year-over-year growth 2019-2023 (%)
Exhibit 22: Cardiac monitoring devices - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Cardiac monitoring devices - Year-over-year growth 2019-2023 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2018-2023 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 29: North America - Year-over-year growth 2019-2023 (%)
Exhibit 30: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 32: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 34: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Impact of drivers and challenges
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Abbott Laboratories - Vendor overview
Exhibit 46: Abbott Laboratories - Business segments
Exhibit 47: Abbott Laboratories - Organizational developments
Exhibit 48: Abbott Laboratories - Geographic focus
Exhibit 49: Abbott Laboratories - Segment focus
Exhibit 50: Abbott Laboratories - Key offerings
Exhibit 51: Abiomed Inc. - Vendor overview
Exhibit 52: Abiomed Inc. - Business segments
Exhibit 53: Abiomed Inc. - Organizational developments
Exhibit 54: Abiomed Inc. - Geographic focus
Exhibit 55: Abiomed Inc. - Key offerings
Exhibit 56: Asahi Kasei Corp. - Vendor overview
Exhibit 57: Asahi Kasei Corp. - Business segments
Exhibit 58: Asahi Kasei Corp. - Organizational developments
Exhibit 59: Asahi Kasei Corp. - Geographic focus
Exhibit 60: Asahi Kasei Corp. - Segment focus
Exhibit 61: Asahi Kasei Corp. - Key offerings
Exhibit 62: Biotronik Inc. - Vendor overview
Exhibit 63: Biotronik Inc. - Business segments
Exhibit 64: Biotronik Inc. - Organizational developments
Exhibit 65: Biotronik Inc. - Key offerings
Exhibit 66: Boston Scientific Corp. - Vendor overview
Exhibit 67: Boston Scientific Corp. - Business segments
Exhibit 68: Boston Scientific Corp. - Organizational developments
Exhibit 69: Boston Scientific Corp. - Geographic focus
Exhibit 70: Boston Scientific Corp. - Segment focus
Exhibit 71: Boston Scientific Corp. - Key offerings
Exhibit 72: General Electric Co. - Vendor overview
Exhibit 73: General Electric Co. - Business segments
Exhibit 74: General Electric Co. - Organizational developments
Exhibit 75: General Electric Co. - Geographic focus
Exhibit 76: General Electric Co. - Segment focus
Exhibit 77: General Electric Co. - Key offerings
Exhibit 78: Hill-Rom Holdings Inc. - Vendor overview
Exhibit 79: Hill-Rom Holdings Inc. - Business segments
Exhibit 80: Hill-Rom Holdings Inc. - Organizational developments
Exhibit 81: Hill-Rom Holdings Inc. - Geographic focus
Exhibit 82: Hill-Rom Holdings Inc. - Segment focus
Exhibit 83: Hill-Rom Holdings Inc. - Key offerings
Exhibit 84: Koninklijke Philips NV - Vendor overview
Exhibit 85: Koninklijke Philips NV - Business segments
Exhibit 86: Koninklijke Philips NV - Organizational developments
Exhibit 87: Koninklijke Philips NV - Geographic focus
Exhibit 88: Koninklijke Philips NV - Segment focus
Exhibit 89: Koninklijke Philips NV - Key offerings
Exhibit 90: Medtronic Plc - Vendor overview
Exhibit 91: Medtronic Plc - Business segments
Exhibit 92: Medtronic Plc - Organizational developments
Exhibit 93: Medtronic Plc - Geographic focus
Exhibit 94: Medtronic Plc - Segment focus
Exhibit 95: Medtronic Plc - Key offerings
Exhibit 96: SCHILLER AG - Vendor overview
Exhibit 97: SCHILLER AG - Product segments
Exhibit 98: SCHILLER AG - Organizational developments
Exhibit 99: SCHILLER AG - Key offerings
Exhibit 100: Validation techniques employed for market sizing
Exhibit 101: Definition of market positioning of vendors
PART 02: SCOPE OF THE REPORT
- Preface
- Currency conversion rates for US$
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
- Market segmentation by product
- Comparison by product
- Cardiac rhythm management devices - Market size and forecast 2018-2023
- Cardiac monitoring devices - Market size and forecast 2018-2023
- Market opportunity by product
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- Asia - Market size and forecast 2018-2023
- ROW - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
- Market drivers
- Market challenges
- Increasing number of acquisition and strategic collaborations
- Increasing R&D focus
- Increasing utilization of cardiac implants
- Overview
- Landscape disruption
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Abbott Laboratories
- Abiomed Inc.
- Asahi Kasei Corp.
- Biotronik Inc.
- Boston Scientific Corp.
- General Electric Co.
- Hill-Rom Holdings Inc.
- Koninklijke Philips NV
- Medtronic Plc
- SCHILLER AG
- Research methodology
- List of abbreviations
- Definition of market positioning of vendors
Exhibit 01: Product overview
Exhibit 02: Global medical devices market
Exhibit 03: Segments of global medical devices market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Product - Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: Cardiac rhythm management devices - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Cardiac rhythm management devices - Year-over-year growth 2019-2023 (%)
Exhibit 22: Cardiac monitoring devices - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Cardiac monitoring devices - Year-over-year growth 2019-2023 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2018-2023 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 29: North America - Year-over-year growth 2019-2023 (%)
Exhibit 30: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 32: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 34: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Impact of drivers and challenges
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Abbott Laboratories - Vendor overview
Exhibit 46: Abbott Laboratories - Business segments
Exhibit 47: Abbott Laboratories - Organizational developments
Exhibit 48: Abbott Laboratories - Geographic focus
Exhibit 49: Abbott Laboratories - Segment focus
Exhibit 50: Abbott Laboratories - Key offerings
Exhibit 51: Abiomed Inc. - Vendor overview
Exhibit 52: Abiomed Inc. - Business segments
Exhibit 53: Abiomed Inc. - Organizational developments
Exhibit 54: Abiomed Inc. - Geographic focus
Exhibit 55: Abiomed Inc. - Key offerings
Exhibit 56: Asahi Kasei Corp. - Vendor overview
Exhibit 57: Asahi Kasei Corp. - Business segments
Exhibit 58: Asahi Kasei Corp. - Organizational developments
Exhibit 59: Asahi Kasei Corp. - Geographic focus
Exhibit 60: Asahi Kasei Corp. - Segment focus
Exhibit 61: Asahi Kasei Corp. - Key offerings
Exhibit 62: Biotronik Inc. - Vendor overview
Exhibit 63: Biotronik Inc. - Business segments
Exhibit 64: Biotronik Inc. - Organizational developments
Exhibit 65: Biotronik Inc. - Key offerings
Exhibit 66: Boston Scientific Corp. - Vendor overview
Exhibit 67: Boston Scientific Corp. - Business segments
Exhibit 68: Boston Scientific Corp. - Organizational developments
Exhibit 69: Boston Scientific Corp. - Geographic focus
Exhibit 70: Boston Scientific Corp. - Segment focus
Exhibit 71: Boston Scientific Corp. - Key offerings
Exhibit 72: General Electric Co. - Vendor overview
Exhibit 73: General Electric Co. - Business segments
Exhibit 74: General Electric Co. - Organizational developments
Exhibit 75: General Electric Co. - Geographic focus
Exhibit 76: General Electric Co. - Segment focus
Exhibit 77: General Electric Co. - Key offerings
Exhibit 78: Hill-Rom Holdings Inc. - Vendor overview
Exhibit 79: Hill-Rom Holdings Inc. - Business segments
Exhibit 80: Hill-Rom Holdings Inc. - Organizational developments
Exhibit 81: Hill-Rom Holdings Inc. - Geographic focus
Exhibit 82: Hill-Rom Holdings Inc. - Segment focus
Exhibit 83: Hill-Rom Holdings Inc. - Key offerings
Exhibit 84: Koninklijke Philips NV - Vendor overview
Exhibit 85: Koninklijke Philips NV - Business segments
Exhibit 86: Koninklijke Philips NV - Organizational developments
Exhibit 87: Koninklijke Philips NV - Geographic focus
Exhibit 88: Koninklijke Philips NV - Segment focus
Exhibit 89: Koninklijke Philips NV - Key offerings
Exhibit 90: Medtronic Plc - Vendor overview
Exhibit 91: Medtronic Plc - Business segments
Exhibit 92: Medtronic Plc - Organizational developments
Exhibit 93: Medtronic Plc - Geographic focus
Exhibit 94: Medtronic Plc - Segment focus
Exhibit 95: Medtronic Plc - Key offerings
Exhibit 96: SCHILLER AG - Vendor overview
Exhibit 97: SCHILLER AG - Product segments
Exhibit 98: SCHILLER AG - Organizational developments
Exhibit 99: SCHILLER AG - Key offerings
Exhibit 100: Validation techniques employed for market sizing
Exhibit 101: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
3 of 4
LOADING...
4 of 4
FEATURED COMPANIES
- Abbott Laboratories
- Abiomed Inc.
- Asahi Kasei Corp.
- Biotronik Inc.
- Boston Scientific Corp.
- General Electric Co.
- MORE
The following companies are recognised as the key players in the global cardiac monitoring & cardiac rhythm management devices market: Abbott Laboratories, Abiomed Inc., Asahi Kasei Corp., Biotronik Inc., Boston Scientific Corp., General Electric Co., Hill-Rom Holdings Inc., Koninklijke Philips NV, Medtronic Plc, SCHILLER AG.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the increasing use of cardiac implants.”
According to the report, one of the major drivers for this market is the increasing awareness initiatives and access to healthcare.
Further, the report states that one of the major factors hindering the growth of this market is the shortage of skilled clinicians.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the increasing use of cardiac implants.”
According to the report, one of the major drivers for this market is the increasing awareness initiatives and access to healthcare.
Further, the report states that one of the major factors hindering the growth of this market is the shortage of skilled clinicians.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
- Abbott Laboratories
- Abiomed Inc.
- Asahi Kasei Corp.
- Biotronik Inc.
- Boston Scientific Corp.
- General Electric Co.
- Hill-Rom Holdings Inc.
- Koninklijke Philips NV
- Medtronic Plc
- SCHILLER AG.
Note: Product cover images may vary from those shown
